Progress in studies on pharmacological action and safety of sodium valproate's metabolites 2-propyl-2-pentenoic acid
10.3760/cma.j.issn.1008-5734.2015.06.009
- VernacularTitle:丙戊酸钠代谢产物2-丙基-2-戊烯酸的药理作用和安全性研究进展
- Author:
Longkuan LI
1
;
Juan XIE
1
Author Information
1. 贵州省人民医院药剂科, 贵阳,550002
- Publication Type:Journal Article
- Keywords:
Valproic acid;
Metabolic detoxication,drug
- From:
Adverse Drug Reactions Journal
2015;(6):436-439
- CountryChina
- Language:Chinese
-
Abstract:
Valproic acid is metabolized via β-oxidation in the body and produces 2-propyl-2-pentenoic acid(2-ene-VPA)which has antiepileptic activity and sedation but also has certain hepatotoxicity and neurotoxicity. 2-ene-VPA is eliminated slowly than VPA and has a high binding protein as to VPA. Hepatotoxicity of 2-ene-VPA is lesser than VPA but also can interfere with the normal oxidation of fatty acid. The valproic acid-induced hyperammonemic encephalopathy may refer to the accumulation of 2-ene-VPA in brain. The pharmacological action and safety of 2-ene-VPA need more pre-clinical evaluation.